Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Spironolactone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Spironolactone 25mg tablets
0202030S0AAATAT
|
Spironolactone | Spironolactone | Cardiovascular System | 421,393 |
|
Spironolactone 50mg tablets
0202030S0AAAUAU
|
Spironolactone | Spironolactone | Cardiovascular System | 97,861 |
|
Spironolactone 100mg tablets
0202030S0AAAVAV
|
Spironolactone | Spironolactone | Cardiovascular System | 62,873 |
|
Spironolactone 12.5mg tablets
0202030S0AAEGEG
|
Spironolactone | Spironolactone | Cardiovascular System | 57,915 |
|
Spironolactone 50mg/5ml oral suspension
0202030S0AAEBEB
|
Spironolactone | Spironolactone | Cardiovascular System | 1,121 |
|
Spironolactone 25mg/5ml oral suspension
0202030S0AAEAEA
|
Spironolactone | Spironolactone | Cardiovascular System | 522 |
|
Spironolactone 5mg/5ml oral suspension
0202030S0AAECEC
|
Spironolactone | Spironolactone | Cardiovascular System | 295 |
|
Aldactone 25mg tablets
0202030S0BBAAAT
|
Aldactone | Spironolactone | Cardiovascular System | 269 |
|
Spironolactone 50mg/5ml oral solution
0202030S0AACPCP
|
Spironolactone | Spironolactone | Cardiovascular System | 211 |
|
Spironolactone 10mg/5ml oral suspension
0202030S0AAEDED
|
Spironolactone | Spironolactone | Cardiovascular System | 154 |
|
Spironolactone 50mg/5ml oral solution sugar free
0202030S0AAEHEH
|
Spironolactone | Spironolactone | Cardiovascular System | 128 |
|
Spironolactone 25mg/5ml oral solution
0202030S0AAEFEF
|
Spironolactone | Spironolactone | Cardiovascular System | 116 |
|
Aldactone 100mg tablets
0202030S0BBACAV
|
Aldactone | Spironolactone | Cardiovascular System | 85 |
|
Spironolactone 25mg/5ml oral solution sugar free
0202030S0AAEIEI
|
Spironolactone | Spironolactone | Cardiovascular System | 80 |
|
Spironolactone 100mg/5ml oral suspension
0202030S0AAEEEE
|
Spironolactone | Spironolactone | Cardiovascular System | 77 |
|
Aldactone 50mg tablets
0202030S0BBABAU
|
Aldactone | Spironolactone | Cardiovascular System | 71 |
|
Spironolactone 5mg/5ml oral solution
0202030S0AACMCM
|
Spironolactone | Spironolactone | Cardiovascular System | 33 |
|
Spironolactone 10mg/5ml oral solution
0202030S0AACQCQ
|
Spironolactone | Spironolactone | Cardiovascular System | 16 |
|
Urospir 50mg/5ml oral solution
0202030S0BKAAEH
|
Urospir | Spironolactone | Cardiovascular System | 7 |
|
Spironolactone 15mg/5ml oral suspension
0202030S0AADCDC
|
Spironolactone | Spironolactone | Cardiovascular System | 5 |
|
Urospir 25mg/5ml oral solution
0202030S0BKABEI
|
Urospir | Spironolactone | Cardiovascular System | 4 |
|
Spironolactone 100mg/5ml oral solution
0202030S0AACRCR
|
Spironolactone | Spironolactone | Cardiovascular System | 2 |
|
Spironolactone 250mg/5ml oral liquid
0202030S0AACZCZ
|
Spironolactone | Spironolactone | Cardiovascular System | 2 |
|
Qaialdo 10mg/ml oral suspension
0202030S0BLAAEB
|
Qaialdo | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 1.25mg/5ml oral liquid
0202030S0AADPDP
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.